封面
市場調查報告書
商品編碼
1451733

2024-2032 年按產品、疾病、給藥途徑、配銷通路和地區分類的豬隻保健品市場報告

Swine Healthcare Market Report by Product, Disease, Route of Administration, Distribution Channel, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年,全球豬隻保健市場規模達到30億美元。展望未來, IMARC Group預計到2032年市場規模將達到53億美元,2024-2032年複合年成長率(CAGR)為6.48%。對生豬產品的日益依賴、商業生豬養殖和出口活動的大幅增加以及對豬肉傳播疾病的認知不斷增強,是推動市場發展的一些關鍵因素。

豬保健是指一系列旨在減輕豬疾病期間不適的產品、治療程序和診斷試劑盒。它的重點是治療不孕症和先天性異常等與豬相關的常見疾病,以及開發預防此類疾病的療法。協調的全球疾病監測、最大限度地減少未來威脅影響的有針對性的研究投資以及資料分析是豬隻醫療保健管理的一部分。除此之外,它還包括預防病毒和細菌,同時透過適當的定時疫苗接種和負責任的抗生素使用來增強牛群疾病免疫力。除了為生豬提供健康服務外,生豬醫療保健系統還透過豬舍設計、豬隻運輸、疫苗接種方案、豬群健康監測、疾病監測和適合具體情況的診斷測試,促進最大限度地降低疾病風險。

群眾對生豬產品的依賴程度不斷增加是推動市場成長的關鍵因素之一。這可以歸因於全球商業養豬和出口活動的大幅成長。同時,包括豬流感、沙門氏菌、豬肺炎支原體和豬瘟(CSF)在內的多種疾病的盛行率不斷上升,正在推動市場的發展。此外,人們對豬肉傳播疾病的認知不斷增強,導致豬隻保健品的使用量增加。此外,政府機構為維護豬隻的健康所採取的有利措施也推動了市場的成長。不斷成長的豬肉消費群體推動了對健康生豬牲畜的需求,這進一步為市場提供了動力。除此之外,廣泛的研發(R&D)活動,尤其是開發預防豬流感和豬瘟的疫苗以及減少豬病對人類的影響,也為市場做出了貢獻。此外,獸醫醫院擴大採用診斷影像,導致對配件和診斷設備的需求不斷增加,這也為市場做出了貢獻。創造積極市場前景的其他一些因素包括疫苗、抗生素和手術治療的採用率不斷提高,以提高牲畜產量,食源性疾病發病率顯著上升,全球化的迅速發展,對有機豬肉的需求不斷增加,以及相當大的食品和飲料 (F&B) 行業的成長。

本報告回答的關鍵問題

  • 全球豬保健市場有多大?
  • 2024-2032年全球豬隻保健市場的預期成長率是多少?
  • 推動全球豬保健市場的關鍵因素是什麼?
  • COVID-19 對全球豬隻保健市場有何影響?
  • 根據該產品,全球豬保健品市場的細分如何?
  • 基於該疾病,全球豬保健市場的細分如何?
  • 全球豬隻保健品市場的重點區域有哪些?
  • 全球豬保健市場的主要參與者/公司有哪些?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球豬保健市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:市場區隔:依產品

  • 診斷測試
    • 市場走向
    • 關鍵環節
      • 酵素連結免疫吸附測定法 (ELISA)
      • 快速免疫遷移(RIM)
      • 瓊脂凝膠免疫擴散 (AGID)
      • 聚合酶鍊式反應 (PCR)
      • 診斷影像
      • 其他
    • 市場預測
  • 療法
    • 市場走向
    • 關鍵環節
      • 疫苗
      • 殺寄生蟲劑
      • 抗感染藥
      • 飼料添加劑
      • 其他
    • 市場預測

第 7 章:市場區隔:依疾病分類

  • 滲出性皮膚炎
    • 市場走向
    • 市場預測
  • 球蟲病
    • 市場走向
    • 市場預測
  • 呼吸疾病
    • 市場走向
    • 市場預測
  • 豬痢疾
    • 市場走向
    • 市場預測
  • 豬細小病毒
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章:市場區隔:依管理途徑

  • 可注射
    • 市場走向
    • 市場預測
  • 口服
    • 市場走向
    • 市場預測

第 9 章:市場區隔:按配銷通路

  • 獸醫院
    • 市場走向
    • 市場預測
  • 零售藥房
    • 市場走向
    • 市場預測
  • 網路藥房
    • 市場走向
    • 市場預測

第 10 章:市場區隔:按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分:按國家/地區
    • 市場預測

第 11 章:促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 12 章:價值鏈分析

第 13 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章:價格分析

第15章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Boehringer Ingelheim International GmbH
    • Ceva Animal Health Inc.
    • Elanco
    • IDEXX Laboratories Inc.
    • Innovative Diagnostic
    • Merck & Co. Inc.
    • Phibro Animal Health Corporation
    • Vetoquinol
    • Virbac Corporation
    • Zoetis Inc.
Product Code: SR112024A6654

The global swine healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.48% during 2024-2032. The increasing dependency on swine products, a considerable rise in commercial swine farming and export activities, and the growing awareness regarding pork-transmitted diseases represent some of the key factors driving the market.

Swine healthcare refers to a broad category of products, treatment procedures, and diagnostic kits that aim to alleviate discomfort during swine diseases. It focuses on treatments for common pig-related disorders like infertility and congenital anomalies as well as the development of therapeutics to prevent such diseases. Coordinated global disease monitoring, targeted research investments that minimize future threat effects, and data analysis are part of swine healthcare management. Along with this, it involves the prevention of viruses and bacteria while enhancing herd disease immunity with appropriately timed vaccinations and responsible antibiotic use. In addition to providing health services to pigs, the swine healthcare system promotes minimizing disease risks through barn design, pig movement, vaccination protocols, herd health monitoring, disease surveillance, and diagnostic tests that are appropriate for the situation.

The increasing dependency on swine products among the masses is one of the key factors driving the growth of the market. This can be attributed to a considerable rise in commercial swine farming and export activities across the globe. In line with this, the rising prevalence of numerous diseases, including swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF), is fueling the market. Moreover, the augmenting awareness regarding pork-transmitted diseases is resulting in a higher uptake of swine healthcare products. Also, favorable initiatives taken by government bodies toward swine health maintenance are fueling the market growth. The continuously growing pork-eating population is propelling the demand for healthy swine livestock, which is further providing an impetus to the market. Besides this, extensive research and development (R&D) activities with an enhanced focus on the development of vaccines to prevent swine flu and swine fever and reduce the effects of swine diseases on humans are contributing to the market. Additionally, the augmenting incorporation of diagnostic imaging in veterinary hospitals leading to an escalating demand for accessories and diagnostic equipment is contributing to the market. Some of the other factors creating a positive market outlook include the growing adoption rates of vaccines, antibiotics, and surgical treatments for increasing livestock production, a significant rise in the rates of foodborne diseases, rapid globalization, the accelerating demand for organic pork, and considerable growth in the food and beverage (F&B) industry.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global swine healthcare market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, disease, route of administration and distribution channel.

Product Insights:

Diagnostic Tests

Enzyme Linked Immuno-Sorbent Assay (ELISA)

Rapid Immuno Migration (RIM)

Agar Gel Immuno-Diffusion (AGID)

Polymerase Chain Reaction (PCR)

Diagnostic Imaging

Others

Therapeutics

Vaccines

Parasiticides

Anti-infectives

Feed Additives

Others

The report has also provided a detailed breakup and analysis of the swine healthcare market based on the product. This includes diagnostic tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and others) and therapeutics (vaccines, parasiticides, anti-infectives, feed additives, and others). According to the report, therapeutics represented the largest segment.

Disease Insights:

Exudative Dermatitis

Coccidiosis

Respiratory Diseases

Swine Dysentery

Porcine Parvovirus

Others

A detailed breakup and analysis of the swine healthcare market based on the disease has also been provided in the report. This includes exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, porcine parvovirus, and others. According to the report, respiratory diseases accounted for the largest market share.

Route of Administration Insights:

Injectable

Oral

A detailed breakup and analysis of the swine healthcare market based on the route of administration has also been provided in the report. This includes injectable and oral.

Distribution Channel Insights:

Veterinary Hospitals

Retail Pharmacy

Online Pharmacy

A detailed breakup and analysis of the swine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals, retail pharmacy and online pharmacy.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for swine healthcare. Some of the factors driving the North America swine healthcare market included the growing consumption of pork, improving animal healthcare infrastructure, the growing consciousness regarding pork-transmitted diseases, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global swine healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., Elanco, IDEXX Laboratories Inc., Innovative Diagnostic, Merck & Co. Inc., Phibro Animal Health Corporation, Vetoquinol, Virbac Corporation, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global swine healthcare market?
  • 2. What is the expected growth rate of the global swine healthcare market during 2024-2032?
  • 3. What are the key factors driving the global swine healthcare market?
  • 4. What has been the impact of COVID-19 on the global swine healthcare market?
  • 5. What is the breakup of the global swine healthcare market based on the product?
  • 6. What is the breakup of the global swine healthcare market based on the disease?
  • 7. What are the key regions in the global swine healthcare market?
  • 8. Who are the key players/companies in the global swine healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Swine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostic Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
      • 6.1.2.2 Rapid Immuno Migration (RIM)
      • 6.1.2.3 Agar Gel Immuno-Diffusion (AGID)
      • 6.1.2.4 Polymerase Chain Reaction (PCR)
      • 6.1.2.5 Diagnostic Imaging
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Vaccines
      • 6.2.2.2 Parasiticides
      • 6.2.2.3 Anti-infectives
      • 6.2.2.4 Feed Additives
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Disease

  • 7.1 Exudative Dermatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Coccidiosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Respiratory Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Swine Dysentery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Porcine Parvovirus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Animal Health Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 IDEXX Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Innovative Diagnostic
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Phibro Animal Health Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Vetoquinol
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Virbac Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Zoetis Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

  • Figure 1: Global: Swine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Swine Healthcare Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Swine Healthcare Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Swine Healthcare Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Swine Healthcare Market: Breakup by Disease (in %), 2023
  • Figure 6: Global: Swine Healthcare Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Swine Healthcare Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Swine Healthcare Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Swine Healthcare (Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Swine Healthcare (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Swine Healthcare (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Swine Healthcare (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Swine Healthcare (Exudative Dermatitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Swine Healthcare (Exudative Dermatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Swine Healthcare (Coccidiosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Swine Healthcare (Coccidiosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Swine Healthcare (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Swine Healthcare (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Swine Healthcare (Swine Dysentery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Swine Healthcare (Swine Dysentery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Swine Healthcare (Porcine Parvovirus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Swine Healthcare (Porcine Parvovirus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Swine Healthcare (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Swine Healthcare (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Swine Healthcare (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Swine Healthcare (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Swine Healthcare (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Swine Healthcare (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Swine Healthcare (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Swine Healthcare (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Swine Healthcare (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Swine Healthcare (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Swine Healthcare (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Swine Healthcare (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Swine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Swine Healthcare Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Swine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Swine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Swine Healthcare Industry: Value Chain Analysis
  • Figure 86: Global: Swine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Swine Healthcare Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Swine Healthcare Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Swine Healthcare Market Forecast: Breakup by Disease (in Million US$), 2024-2032
  • Table 4: Global: Swine Healthcare Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Swine Healthcare Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Swine Healthcare Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Swine Healthcare Market: Competitive Structure
  • Table 8: Global: Swine Healthcare Market: Key Players